We are pleased to announce that our 6-month clinical data abstract has been accepted for Poster Presentation at the upcoming ICS 2018 Meeting 28-31 August in Philadelphia, USA.

The Urolon™ European Clinical Trial reaches another milestone; all patients have now completed their 12-month follow-up visit.

We are delighted to announce that Urolon™ has received CE certification! Urolon™ is a safe and effective bioresorbable urethral bulking agent for the treatment of stress urinary incontinence (SUI).

Emergency and Aid workers work tirelessly to protect human lives yet aggression and violence against them is on the increase.

The AQLANE Medical™ European Clinical Trial continues to make progress as subjects reach their 12-month follow-up!